ArticleJournal of autism and developmental disorders2026
A Telehealth Diagnostic Tool for Autistic Children With Phrased and Fluent Speech: Comparison to In-person Diagnosis.
Article in Journal of autism and developmental disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
purposeGiven the existing barriers to timely ASD diagnosis and the potential of telehealth to mitigate these barriers, it is critical to create and validate telehealth autism diagnostic instruments. Existing instruments largely focus on children under 3 and/or those with minimal verbal speech. We created and investigated the accuracy and validity for two novel instruments: Tele-ASD-KIDS, phrased speech (TAK-PS), and Tele-ASD-KIDS, fluent speech (TAK-FS) alongside an existing measure for minimally verbal children -the Tele-ASD-PEDS (TAP).
methodsWe assessed 39 children for autism in a university-based free clinic, both in-person and using telehealth, with blinded assessment teams- TAP (n = 10; M = 47.5 months), TAK-PS (n = 7, M = 74 months), TAK-FS (n = 22, M = 102.77 months). Data were analyzed for diagnostic accuracy and social validity for each telehealth instrument separately.
resultsOur findings suggest that the TAK-PS is highly accurate, whereas the TAK-FS is accurate for some children but not others. Older children, those with behaviors unrelated to ASD that may affect social-communication abilities, and those with ADHD appear least likely to benefit from telehealth diagnostic assessments. For social validity, caregivers were largely satisfied with both TAK versions.
conclusionsThe TAK-PS and TAK-FS are, to our knowledge, the first telehealth diagnostic measures for ASD in children with phrased or fluent speech that have been systematically compared to in-person assessments using blinded clinical teams and randomized assessment order. Although the initial accuracy and validity of these measures are promising, more research on these measures is needed.
Indexed as
Identifiers
42068510What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.